Novavax
NVAX
#5793
Rank
ยฃ0.81 B
Marketcap
ยฃ5.04
Share price
0.90%
Change (1 day)
-26.58%
Change (1 year)

Novavax (NVAX) - P/B ratio

P/B ratio as of December 2025 : -6.93

According to Novavax's latest financial reports the company has a price-to-book ratio of 1.05971.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Novavax - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31-6.81220.51%
2024-12-31-2.13167.32%
2023-12-31-0.7953-42.29%
2022-12-31-1.38-95.52%
2021-12-31-30.8-371.78%
2020-12-3111.3-1735.05%
2019-12-31-0.6922-83.57%
2018-12-31-4.21-7.94%
2017-12-31-4.58-92.57%
2016-12-31-61.6-896.25%
2015-12-317.7425.48%
2014-12-316.1717.34%
2013-12-315.2650.85%
2012-12-313.4829.53%
2011-12-312.69-41.12%
2010-12-314.5719.85%
2009-12-313.8132.66%
2008-12-312.87-12.14%
2007-12-313.2721.37%
2006-12-312.70-36.5%
2005-12-314.249.54%
2004-12-313.87-33.15%
2003-12-315.80-27.94%
2002-12-318.04

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Agenus
AGEN
-0.4250-93.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
1.61-123.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
1.13-116.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-3.96-42.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6.11-188.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
1.53-122.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.80-183.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
3.64-152.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
4.65-167.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
2.81-140.54%๐Ÿ‡บ๐Ÿ‡ธ USA